Executive Profile

Sol J. Barer Ph.D. Secretary and Director, BioNJ Inc.

Age	Total Calculated Compensation	This person is connected to 12 Board Members in 12 different organizations across 13 different industries. See Board Relationships
65	--

Background

Dr. Sol J. Barer, Ph.D., serves as a Secretary of BioNJ Inc. Dr. Barer is Managing Partner of SJ Barer Consulting. He is a biotechnology industry veteran, and serves as a senior advisor to a number of other biotechnology companies. He founded Celgene Corporation. He is a consultant to Celgene on strategic matters and research and development. He has been the Principal Executive of Celgene Corporation over 25 years, and has led Celgene to become the 3rd largest independent ... biotechnology company in the world and a member of the S&P500 with a current market capitalization exceeding $25 billion. He has over 30 years of experience with publicly traded biotechnology companies. In 1980, when he was with Celanese Research Company, he formed the biotechnology group that was subsequently spun out to form Celgene. Dr. Barer served as the Chief Executive Officer of Celgene Corporation from May 1, 2006 to June 16, 2010 and its President from October 1993 to May 1, 2006; Chief Operating Officer from March 1994 to May 1, 2006. He joined Celgene in 1987. He worked with Celanese Corporation, where he served as Senior Vice President of Science and Technology and served as its Vice President and General Manager of Chiral Products from October 1990 to October 1993. Dr. Barer served as Vice President of Technology at Celgene Corp. from September 1987 to October 1990. He joined the Celanese Research Company in 1974 and formed the biotechnology group that was subsequently spun out to form Celgene. He has been Chair of Scientific Advisory Board at MYOS Corp. since June 27, 2012. He has been Chairman of the Board of InspireMD, Inc. since November 16, 2011. He has been Chairman of Cerecor, Inc. since January 10, 2012, Medgenics, Inc. since June 30, 2012 and ContraFect Corp. since March 8, 2012. He has been Chairman of Edge Therapeutics, Inc. since January 1, 2013. He served as Executive Chairman of Celgene Corporation from January 2011 to June 15, 2011 and also from May 2006 to June 2010. He served as Executive Chairman of Celgene Corporation from June 2010 to January 2011. He served as the Chairman of the Board at Semorex Inc. He has been a Director of Edge Therapeutics, Inc. since September 1, 2011. Dr. Barer has been a Director of InspireMD, Inc. since July 11, 2011; Amicus Therapeutics, Inc. since January 2009; Aegerion Pharmaceuticals, Inc since May 1, 2011 and ContraFect Corp. since February 24, 2011. He serves as a Director of Semerex, Inc. He serves as a Director of BioNJ Inc. He serves as Member of Scientific Advisory Board at MYOS Corp. He serves on the editorial board of Biocatalysis. He serves as Director of Cerecor, Inc. He serves as a Member of Scientific Advisory Board at Heat Biologics, Inc. He has been Member of Strategic Advisory Board of The SpendSmart Payments Company, Inc. (also known as BillMyParents, Inc) since September 2012. He served as an Executive Director of Celgene Corporation from March 1994 to December 31, 2010 and its Director from January 1, 2011 to June 15, 2011. He served as a Director of Semorex Inc., Nobex Inc. and Nobex Corporation. He serves as the Chairman of the Board of Trustees of the Biotechnology Council of New Jersey. He serves as the Founding Chairman of the Rutgers Graduate School Dean's Advisory Council and the Rutgers Bioscience Commercialization Advisory Board. He serves on the New Jersey Commission of Science and Technology. He serves as Board of Trustees of Rutgers University. He serves on the Board of Trustees of the Biotechnology Council of New Jersey and the Board of the Brooklyn College Foundation the Board of Trustees of Rutgers - The State University of New Jersey and the Board of the Tourette Syndrome Association. Dr. Barer served as Commissioner of the New Jersey Commission on Science and Technology. He served as a Member of Scientific and Clinical Advisory Board at Heat Biologics, Inc. since June 2011. He holds a number of patents and publications. He holds a BS from Brooklyn College. He received a PhD in Organic and Physical Chemistry from Rutgers University.

Corporate Headquarters 1255 Whitehorse-Mercerville Road Trenton, New Jersey 08691 United States Phone: 609-890-3185 Fax: 609-581-8244 Board Members Memberships Former Director Nobex Corporation Secretary and Director BioNJ Inc. Former Executive Chairman and Chairman of Executive Committee Celgene Corporation Chairman and Director Semorex Inc. Chairman Cerecor, Inc. 2009-Present Director and Member of Compensation Committee Amicus Therapeutics, Inc. 2011-Present Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee Aegerion Pharmaceuticals, Inc. 2011-Present Chairman, Member of Audit Committee, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee InspireMD, Inc. 2011-Present Chairman and Chairman of Compensation Committee Edge Therapeutics, Inc. 2011-Present Chairman of The Board ContraFect Corp 2012-Present Chairman and Member of Nominating & Corporate Governance Committee Medgenics, Inc. Education PhD Rutgers, The State University of New Jersey BS Brooklyn College Other Affiliations Nobex Corporation Celgene Corporation Medgenics, Inc. Rutgers, The State University of New Jersey Brooklyn College Amicus Therapeutics, Inc. Aegerion Pharmaceuticals, Inc. InspireMD, Inc. Semorex Inc. The SpendSmart Payments Company, Inc. MYOS Corp. Edge Therapeutics, Inc. Heat Biologics, Inc. ContraFect Corp Cerecor, Inc.

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.